HARRISBURG — Following the approval process by the federal government, the state Department of Health confirmed that children ages 12 and older are now eligible for a Pfizer COVID-19 vaccine booster dose five months after completing the primary series.

The five-month booster interval was updated from the previous authorization of six months and is applicable to anyone age 12 and older who received the Pfizer BioNTech vaccine for their primary vaccination series.

The U.S. Food and Drug Administration (FDA) also amended the emergency use authorization for the Pfizer COVID-19 vaccine to allow for a third primary series dose for certain immunocompromised children ages 5 to 11, at least 28 days following the second dose.

To find a COVID-19 vaccine provider, visit www.vaccines.gov.